NEW YORK, Dec. 11 (GenomeWeb News) - Ingenium Pharmaceuticals has raised €13.8 million ($16.8 million) in a third round of private-equity financing, the company said today.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
